Kaimi Biotech in MEDICA 2025, Düsseldorf, Germany


As the curtains fell on MEDICA 2025 in Düsseldorf, which ran from November 17 to 20, Our team brought back rich insights, valuable connections, and a renewed sense of mission.Our booth has become an important platform for showcasing our latest products and technologies. The collaborative exchanges with professionals have made us extremely excited.

  

A key highlight of Kaimi Biotech's presence will be the introduction of its innovative new product: Unow™ Drug Test Device-THC Parent Drug. This advanced diagnostic device is engineered for the highly sensitive detection of THC Parent Drug, with a remarkably low detection threshold of 2-5 ng/mL. This high level of sensitivity ensures accurate and reliable results for applications in onsite testing.

As we reflect on this experience, we recognize that MEDICA 2025 was more than just an exhibition; it was a catalyst for growth. The insights gained, relationships built, and inspiration drawn will inform our product development strategy, market expansion efforts, and commitment to innovation. Furthermore, we will prioritize following up with the contacts made during the show to convert promising leads into tangible collaborations.

In conclusion, participating in MEDICA was a transformative experience, We are grateful for the opportunity to engage with the best and brightest in the industry and are energized to translate the knowledge and connections from this event into tangible value for our customers and partners.